Top Precision Medicine Companies in Israel

QRGenetics is focused on precision medicine, particularly for genetic diseases, by leveraging an AI drug-discovery engine that utilizes exclusive analytics and datasets to rapidly identify novel drug targets. This approach not only addresses unmet medical needs but also explores new applications for soon-expired drugs.

Infinity Medical focuses on enhancing digital health startups, including Genoox, which provides a global platform for gathering genetic data. Their Polaris platform optimizes molecular drugs using advanced computing, aligning with the principles of precision medicine.

PRiiMO has created a digital platform that leverages an AI-based precision medicine engine to tailor cancer treatment plans, specifically focusing on prostate cancer. Their mission is to enhance the prevention, diagnosis, and treatment processes by integrating diverse data sources and advanced technologies, ultimately aiming to improve patient outcomes and reduce treatment costs.

Imagene AI is dedicated to enhancing cancer care through rapid and standardized molecular profiling, which aligns with the principles of precision medicine. Their mission is to provide physicians with immediate oncology intelligence, thereby facilitating optimal treatment for cancer patients.

MedAware focuses on enhancing patient safety through its AI-powered medication safety monitoring platform, which identifies preventable medication-related risks at all stages of the patient journey. Their advanced machine learning algorithms provide personalized medication risk identification, ensuring high clinical relevance and continuous monitoring.

MDClone is a healthcare data exploration platform dedicated to transforming patient health and clinical outcomes through innovative data utilization. By empowering healthcare institutions with the ADAMS Platform, MDClone facilitates rapid discovery and collaboration, positioning itself as a leader in healthcare data analytics.

AID Genomics is a diagnostic company dedicated to developing precision medicine-based diagnostic solutions, primarily for oncology, as well as for hereditary rare diseases and infectious diseases. Their mission is to enhance patient care through individualized diagnostics and comprehensive genomic insights, ultimately improving treatment recommendations and outcomes for patients.

MindUP is actively seeking innovative technologies that enhance precision medicine, including an AI platform that targets complex polygenic diseases using genomic and clinical data. Additionally, DermAb.io is developing a clinical decision support system to facilitate personalized biologic prescriptions.

The company is an early-stage startup in the Digital Health sector, concentrating on drug research and development, particularly by leveraging late-stage clinical trials data. Their mission is to assist pharmaceutical companies and researchers in identifying new drug opportunities through advanced data analytics and expertise in clinical and medical sciences.

The company emphasizes its commitment to precision medicine through innovative technologies that enhance patient treatment and outcomes. Notably, Celsee Diagnostics offers a fully automated system for detecting circulating tumor cells, enabling analysis of biomarkers at a single-cell level, while PamGene's platform allows for the measurement of protein activities in individual tumors, aiding in the assessment of drug sensitivity and the discovery of new prognostic biomarkers.